LiveWorld Reports Second Quarter 2025 Financial Results
LiveWorld (OTC:LVWD) reported Q2 2025 financial results with total revenues of $2.7 million, down 5% year-over-year. The company posted a net loss of $92,000, a 31% improvement from Q2 2024's loss of $134,000. Healthcare revenues reached $2.4 million in Q2 2025.
The company's cash position strengthened to $5.5 million, up $729,000 from June 30, 2024. LiveWorld continues to invest heavily in AI across three areas: business operations, client solutions, and next-generation AI software products. Management noted that client spending remains cautious due to current market conditions, expecting this trend to persist.
Additionally, LiveWorld's creative digital marketing campaign for Chiesi Global Rare Diseases was named a finalist in the 2025 MM+M Awards for the Organic Social Media category.
LiveWorld (OTC:LVWD) ha comunicato i risultati finanziari del secondo trimestre 2025 con ricavi totali di $2,7 milioni, in calo del 5% rispetto allo stesso periodo dell'anno precedente. La società ha registrato una perdita netta di $92.000, migliorando del 31% rispetto alla perdita di $134.000 nel Q2 2024. I ricavi nel settore sanitario hanno raggiunto $2,4 milioni nel secondo trimestre 2025.
La posizione di cassa si è rafforzata a $5,5 milioni, in aumento di $729.000 rispetto al 30 giugno 2024. LiveWorld continua a investire in modo consistente nell'IA su tre fronti: operazioni aziendali, soluzioni per i clienti e prodotti software di IA di nuova generazione. La direzione ha rilevato che la spesa dei clienti resta prudente a causa delle condizioni di mercato attuali e prevede che questa tendenza proseguirà.
Inoltre, la campagna digitale creativa di LiveWorld per Chiesi Global Rare Diseases è stata selezionata come finalista ai MM+M Awards 2025 nella categoria Organic Social Media.
LiveWorld (OTC:LVWD) presentó los resultados financieros del segundo trimestre de 2025 con ingresos totales de $2,7 millones, un 5% menos interanual. La compañía registró una pérdida neta de $92.000, una mejora del 31% respecto a la pérdida de $134.000 en el segundo trimestre de 2024. Los ingresos en el área de salud alcanzaron $2,4 millones en el Q2 2025.
La posición de caja se fortaleció hasta $5,5 millones, aumentando $729.000 desde el 30 de junio de 2024. LiveWorld sigue invirtiendo de forma intensiva en IA en tres áreas: operaciones comerciales, soluciones para clientes y productos de software de IA de nueva generación. La dirección señaló que el gasto de los clientes sigue siendo cauteloso debido a las condiciones actuales del mercado y espera que esta tendencia continúe.
Además, la campaña digital creativa de LiveWorld para Chiesi Global Rare Diseases fue seleccionada finalista en los MM+M Awards 2025 en la categoría Organic Social Media.
LiveWorld (OTC:LVWD)는 2025년 2분기 실적을 발표하며 총매출 $2.7 million을 기록해 전년 동기 대비 5% 감소했습니다. 회사는 순손실 $92,000을 보고했으며, 이는 2024년 2분기 손실 134,000달러에 비해 31% 개선된 수치입니다. 의료 부문 매출은 2025년 2분기에 $2.4 million에 달했습니다.
현금 보유액은 $5.5 million로 늘어나 2024년 6월 30일 대비 $729,000 증가했습니다. LiveWorld는 비즈니스 운영, 고객 솔루션, 차세대 AI 소프트웨어 제품의 세 분야에 걸쳐 AI에 대한 대규모 투자를 계속하고 있습니다. 경영진은 현재 시장 여건으로 인해 고객 지출이 신중한 상태이며 이러한 추세가 지속될 것으로 예상한다고 밝혔습니다.
또한 LiveWorld가 Chiesi Global Rare Diseases를 위해 선보인 창의적 디지털 마케팅 캠페인이 2025 MM+M 어워드의 Organic Social Media 부문 결선에 올랐습니다.
LiveWorld (OTC:LVWD) a publié ses résultats du deuxième trimestre 2025 avec un chiffre d'affaires total de 2,7 millions de dollars, en baisse de 5 % sur un an. La société a enregistré une perte nette de 92 000 dollars, soit une amélioration de 31 % par rapport à la perte de 134 000 dollars au T2 2024. Les revenus du secteur santé se sont élevés à 2,4 millions de dollars au T2 2025.
La trésorerie s'est renforcée à 5,5 millions de dollars, en hausse de 729 000 dollars par rapport au 30 juin 2024. LiveWorld continue d'investir massivement dans l'IA dans trois domaines : opérations commerciales, solutions clients et produits logiciels d'IA de prochaine génération. La direction a noté que les dépenses des clients restent prudentes en raison des conditions actuelles du marché et s'attend à ce que cette tendance perdure.
Par ailleurs, la campagne marketing numérique créative de LiveWorld pour Chiesi Global Rare Diseases a été finaliste des MM+M Awards 2025 dans la catégorie Organic Social Media.
LiveWorld (OTC:LVWD) veröffentlichte die Finanzergebnisse für das zweite Quartal 2025 mit einem Gesamtumsatz von $2,7 Millionen, ein Rückgang von 5 % gegenüber dem Vorjahr. Das Unternehmen verzeichnete einen Nettoverlust von $92.000, eine Verbesserung von 31 % gegenüber dem Verlust von $134.000 im Q2 2024. Die Umsätze im Gesundheitsbereich beliefen sich im zweiten Quartal 2025 auf $2,4 Millionen.
Die Barposition hat sich auf $5,5 Millionen erhöht, ein Anstieg um $729.000 gegenüber dem 30. Juni 2024. LiveWorld investiert weiterhin stark in KI in drei Bereichen: Geschäftsabläufe, Kundenlösungen und KI-Softwareprodukte der nächsten Generation. Das Management wies darauf hin, dass die Kundenausgaben aufgrund der aktuellen Marktbedingungen vorsichtig bleiben und rechnet damit, dass dieser Trend anhalten wird.
Außerdem wurde die kreative digitale Marketingkampagne von LiveWorld für Chiesi Global Rare Diseases als Finalist in der Kategorie Organic Social Media bei den MM+M Awards 2025 nominiert.
- Net loss reduced by 31% to $92,000 compared to Q2 2024
- Cash position increased by $729,000 to $5.5 million year-over-year
- Strategic AI investments across three key business areas
- Acquired four new clients in first half of 2025
- Recognition as finalist in 2025 MM+M Awards
- Total revenues declined 5% to $2.7 million year-over-year
- Continued net losses expected due to AI investments
- Clients reducing discretionary spending due to market uncertainty
- Operating expenses increased by 7% to $1.426 million in Q2
LiveWorld continues to increase its AI investment
CAMPBELL, Calif. and NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for second quarter 2025.
Q2 2025 Financial and Business Highlights
- Total three months revenues of
$2.7 million - Healthcare revenues of
$2.4 million in Q2 2025 - Net loss from operations of
$92,000 a reduction of31% when compared to 2024 - Net Cash increased by
$729,000 t o$5.5 million from June 30, 2024 - Acquired four new clients in the first six months of 2025
Management Commentary
“For the three months ended June 30, 2025, we saw a slight dip in total revenues when compared to the same period in 2024. The uncertainty of the current business environment has our clients pulling back on discretionary spending in 2025. We anticipate this to continue for the foreseeable future until we start to see the market stabilize,” commented David Houston, Chief Financial Officer of LiveWorld. “We saw a small loss in the second quarter of
“We continue to invest in AI in three ways: how we operate our business, across all of the solutions we offer our clients, and in next generation AI software-based products,” said Peter Friedman, Chairman and CEO of LiveWorld. “Our intent is to not only improve the efficiency and value of our current offerings but to introduce entirely new AI-based products and revenue streams for future growth.”
The company also announced that its creative digital marketing campaign for Chiesi Global Rare Diseases has been named a finalist in the 2025 MM+M Awards in the Organic Social Media category for disease awareness elevating Chiesi GRD positioning, strengthening patient ties, and building community connections.
Financial Review for the Three and Six Months Ended June 30, 2025
Total revenues for the three months ended June 30, 2025, were approximately
Total revenues for the six months ended June 30, 2025, were approximately
The company reported a net loss for the three months of approximately
The company reported a net loss for the six months of approximately
The company finished the quarter with approximately
Detailed financial information may be downloaded at www.liveworld.com/ir or at https://www.otcmarkets.com/stock/LVWD/overview.
About LiveWorld
LiveWorld is a social-first digital agency and software company that unlocks the full potential of social media to transform customer relationships through integrated compliance, engagement, and insight solutions. We provide brand marketers bold creative rooted in strategy that captivates and resonates, social moderation and engagement that activates interactions, software and AI that enriches and scales customer experiences, and compliance that enables and accelerates digital programs.
With over 29 years of making connections, we leverage our social media DNA to deliver emotion-driven behavior change through digital campaigns with a human touch. LiveWorld clients include the number one brands in pharmaceuticals, healthcare, and financial-travel services. LiveWorld is headquartered in Campbell, California, with an additional office in New York City. Learn more at www.liveworld.com and @LiveWorld.
“Safe Harbor" Statement Under The Private Securities Litigation Reform Act
This press release may contain forward-looking information concerning LiveWorld plans, objectives, future expectations, forecasts and prospects. These statements may include those regarding LiveWorld’s current or future financial performance including but not limited to lists of clients, revenue and profit, use of cash, investments, relationships and the actual or potential impact of stock option expense, and the results of its product development efforts. Actual results may differ materially from those expressed in the forward- looking statements made as a result of, among other things, final accounting adjustments and results, LiveWorld’s ability to attract new clients and preserve or expand its relationship with existing clients, LiveWorld’s ability to retain and attract high quality employees, including its management staff, the ability to deliver new innovative products in a timely manner, changing accounting treatments, and other risks applicable to the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the Company undertakes no obligation to update these forward-looking statements to reflect subsequent events or circumstances.
LiveWorld Contacts
IR Contact:
David Houston
LiveWorld
dhouston@liveworld.com
(408) 615-8496
PR Contact:
Matthew Hammer
LiveWorld
mhammer@liveworld.com
(737) 212-9739
| LIVEWORLD, INC. | |||||||
| UNAUDITED CONDENSED BALANCE SHEETS | |||||||
| (In thousands, except share data) | |||||||
| June 30, | December 31, | ||||||
| 2025 | 2024 | ||||||
| ASSETS | |||||||
| Current assets | |||||||
| Cash and cash equivalent | $ | 5,538 | $ | 6,603 | |||
| Accounts receivable, net | 3,879 | 682 | |||||
| Prepaid expenses | 325 | 290 | |||||
| Total current assets | 9,742 | 7,575 | |||||
| Property and equipment, net | 26 | 33 | |||||
| Other assets | 27 | 27 | |||||
| Total assets | $ | 9,795 | $ | 7,635 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities | |||||||
| Accounts payable | $ | 217 | $ | 182 | |||
| Accrued employee expenses | 543 | 1,068 | |||||
| Other accrued liabilities | 1,746 | 413 | |||||
| Deferred revenue | 2,384 | 860 | |||||
| Total current liabilities | 4,890 | 2,523 | |||||
| Total liabilities | 4,890 | 2,523 | |||||
| Stockholders' equity | |||||||
| Common stock: | 34 | 34 | |||||
| Additional paid-in capital | 144,611 | 144,451 | |||||
| Accumulated deficit | (139,740 | ) | (139,373 | ) | |||
| Total stockholders' equity | 4,905 | 5,112 | |||||
| Total liabilities and stockholders' equity | $ | 9,795 | $ | 7,635 | |||
| LIVEWORLD, INC. | |||||||||||||||
| CONDENSED STATEMENT OF OPERATIONS | |||||||||||||||
| (In thousands, except per share data) | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Total revenues | $ | 2,657 | $ | 2,786 | $ | 5,232 | $ | 5,359 | |||||||
| Cost of revenues | 1,322 | 1,567 | 2,837 | 3,144 | |||||||||||
| Gross Margin | 1,335 | 1,219 | 2,395 | 2,215 | |||||||||||
| Operating Expense | |||||||||||||||
| Product development | 362 | 245 | 637 | 517 | |||||||||||
| Sales and marketing | 455 | 460 | 895 | 970 | |||||||||||
| General and administrative | 609 | 629 | 1,249 | 1,340 | |||||||||||
| Total operating expense | 1,426 | 1,334 | 2,781 | 2,827 | |||||||||||
| Income from operations | (91 | ) | (115 | ) | (386 | ) | (612 | ) | |||||||
| Income before tax | (91 | ) | (115 | ) | (386 | ) | (612 | ) | |||||||
| Other Income | 20 | 1 | 37 | 2 | |||||||||||
| Provision for income taxes | 19 | 20 | 19 | 22 | |||||||||||
| Net income from operations | (92 | ) | (134 | ) | (368 | ) | (632 | ) | |||||||
| Earnings per share analysis from operations: | |||||||||||||||
| Basic income per share | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | |||
| Shares used in computing basic loss per share | 45,633,442 | 45,633,442 | 45,633,442 | 45,633,442 | |||||||||||
| Diluted net income (loss) per share | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | |||
| Shares used in computing diluted income (loss) per share | 45,633,442 | 45,633,442 | 45,633,442 | 45,633,442 | |||||||||||
| Departmental allocation of stock-based compensation: | |||||||||||||||
| Cost of revenues | $ | 21 | $ | 19 | $ | 41 | $ | 38 | |||||||
| Product development | 5 | 5 | 10 | 9 | |||||||||||
| Sales and marketing | 8 | 8 | 16 | 16 | |||||||||||
| General and administrative | 47 | 48 | 93 | 93 | |||||||||||
| Total stock-based compensation | $ | 81 | $ | 80 | $ | 160 | $ | 156 | |||||||
| LIVEWORLD, INC. | |||||||||||||||
| CONDENSED STATEMENTS OF CASH FLOWS | |||||||||||||||
| (In thousands) | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Cash flows from operating activities: | |||||||||||||||
| Net income (loss) | $ | (92 | ) | $ | (134 | ) | $ | (368 | ) | $ | (632 | ) | |||
| Adjustments to reconcile net income (loss) provided by (used in) operating activities: | |||||||||||||||
| Depreciation of long-lived assets | 5 | 6 | 11 | 13 | |||||||||||
| Stock-based compensation | 81 | 80 | 160 | 156 | |||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||
| Accounts receivable | (1,537 | ) | 181 | (3,197 | ) | (381 | ) | ||||||||
| Other assets | 137 | 125 | (32 | ) | ---- | ||||||||||
| Accounts payable | 5 | (14 | ) | 35 | (16 | ) | |||||||||
| Accrued liabilities | 1,370 | 10 | 807 | (204 | ) | ||||||||||
| Deferred revenue | 524 | 203 | 1,523 | 1,207 | |||||||||||
| Net cash provided by (used in) operating activities | 493 | 457 | (1,061 | ) | 143 | ||||||||||
| Cash flows from investing activities: | |||||||||||||||
| Purchase of property and equipment | ----- | (1 | ) | (4 | ) | (6 | ) | ||||||||
| Net cash provided by (used in) investing activities | ----- | (1 | ) | (4 | ) | (6 | ) | ||||||||
| Cash flows from financing activities: | |||||||||||||||
| Proceeds from exercise of stock options | ----- | ---- | ----- | ---- | |||||||||||
| Net cash provided by (used for) financing activities | ----- | ---- | ----- | ---- | |||||||||||
| Change in cash and cash equivalent | 493 | 456 | (1,065 | ) | 137 | ||||||||||
| Cash and cash equivalents, beginning of period | 5,045 | 4,316 | 6,603 | 4,635 | |||||||||||
| Cash and cash equivalents, end of period | $ | 5,538 | $ | 4,772 | $ | 5,538 | $ | 4,772 | |||||||
| Supplemental disclosure of non-cash financing and investing activities: | |||||||||||||||
| Income tax paid | $ | 19 | $ | 20 | $ | 19 | $ | 22 | |||||||
FAQ
What were LiveWorld's (LVWD) Q2 2025 earnings results?
How much cash does LiveWorld (LVWD) have as of Q2 2025?
What is LiveWorld's (LVWD) AI investment strategy?
How did LiveWorld's (LVWD) healthcare revenue perform in Q2 2025?
What is causing the decline in LiveWorld's (LVWD) revenues?
